Cancer BiologybioRxivPreprint
ESR1 fusion proteins invoke breast cancer subtype-dependent enrichment of ligand independent pro-oncogenic signatures and phenotypes
M. E. Yates, Z. Li, Y. Li…·S. Oesterreich
This study shows ER fusion proteins in breast cancer cell lines drive ligand-independent pro-oncogenic pathways, with subtype- and fusion-specific effects.
DOI 10.1101/2023.09.18.558175